This survey is to evaluate patient satisfaction in those currently taking. or have previously taken, Esbriet.
BioNews Services frequently launches surveys to help better understand those within our rare disease communities. The information you provide will offer insight into the needs of patients and caregivers living with Pulmonary Fibrosis.
This short survey will take approximately 2 minutes.
If you have questions please contact:
CONSENT FOR SURVEY PARTICIPATION
There are 9 questions in this survey.